Stocktoria

Shattuck Labs, Inc. STTK

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-10-09
Chart by TradingView
3/9
Piotroski F — financial health
-3.77
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$1.0M$5.7M$1.7M$652,000$30.0M
Operating income-$51.5M-$80.6M-$92.0M-$103.3M-$45.3M
Net income-$48.8M-$75.4M-$87.3M-$101.9M-$45.0M
Operating cash flow-$39.9M-$60.5M-$81.2M-$94.5M-$57.1M
Free cash flow-$40.0M-$60.6M-$81.6M-$106.1M-$65.0M
Total assets$91.0M$91.0M$159.6M$205.3M$298.6M
Total liabilities$8.6M$11.4M$14.9M$29.2M$26.8M
Shareholders' equity$82.4M$79.6M$144.7M$176.2M$271.8M
Ratios
Operating margin-5150.8%-1408.3%-5549.6%-15848.0%-150.8%
Net margin-4880.9%-1318.1%-5268.4%-15635.7%-149.8%
FCF margin-3995.3%-1058.8%-4926.7%-16274.8%-216.7%
Return on assets-53.6%-82.8%-54.7%-49.7%-15.1%
Return on equity-59.2%-94.7%-60.3%-57.9%-16.5%
Current ratio11.708.8812.517.3911.72
Revenue growth-82.5%245.3%154.1%-97.8%202.2%

Notable holders (13F)

InvestorSharesValue
Point72 Asset Management, L.P.1,031,049$6.6M
RENAISSANCE TECHNOLOGIES LLC604,500$3.9M

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -3.77 (distress)

  • Working capital / assets 0.829
  • Retained earnings / assets -4.73
  • EBIT / assets -0.566
  • Equity / liabilities 9.54

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001680367 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.